English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Godrej Agrovet records 33 percent consolidated growth in FY22qrcode

May. 11, 2022

Favorites Print
Forward
May. 11, 2022

Follow

Godrej Agrovet has announcement its fourth quarter results and financial year end results for the year ended March 31, 2022.

Q4 FY22 consolidated total income increased to Rs. 2,133.9 crore from Rs. 1,472.4crore in Q4 FY21, a growth of 44.9% year-on-year.

Consolidated EBITDA, excluding non-recurring & exceptional items, increased to Rs. 193.3 crore from Rs. 124.5 crore in Q4 FY21, a growth of 55.3% year-on-year (reportedgrowth of 82.0% year-on-year).

Q4 FY22 Profit before tax, excluding non-recurring & exceptional items, increasedto Rs. 129.6 crore from Rs. 67.4 crore in Q4 FY21, a growth of 92.4% year-on-year(reported growth of 144.0% year-on-year).

FY22 Financial Summary

FY22 consolidated total income increased to Rs. 8,385.7 crore from Rs. 6,306.3 crore in FY21, a growth of 33.0% year-on-year. Consolidated EBITDA, excluding non-recurring & exceptional items, increased to Rs. 723.2 crore in Q4 FY22 from Rs. 598.1 crore in FY21, a growth of 20.9% year-on-year (reported growth of 23.5% year-on-year).

FY22 Profit before tax, excluding non-recurring & exceptional items, increased to Rs. 486.8 crore from Rs. 397.6 crore in FY21, a growth of 22.4% year-on-year (reported growth of 26.3% year- on-year).

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox